Back to top
more

BioLife Solutions (BLFS)

(Delayed Data from NSDQ)

$18.03 USD

18.03
374,372

-0.13 (-0.72%)

Updated May 3, 2024 04:00 PM ET

After-Market: $18.03 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (156 out of 251)

Industry: Medical - Products

Better trading starts here.

Zacks News

Top Ranked Momentum Stocks to Buy for July 26th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 26th:

    Has BioLife Solutions (BLFS) Outpaced Other Medical Stocks This Year?

    Is (BLFS) Outperforming Other Medical Stocks This Year?

      Top Ranked Momentum Stocks to Buy for July 18th

      Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 18th:

        Zacks.com featured highlights include: CNX, Radcom, BioLife, Momo and Atlas Air

        Zacks.com featured highlights include: CNX, Radcom, BioLife, Momo and Atlas Air

          Improve Your Portfolio With These 5 Top Profitable Stocks

          Profitability analysis is the best way to evaluate a company's ability to provide healthy gains to its investors even after meeting all its business-related expenses.

            Top Ranked Momentum Stocks to Buy for July 13th

            Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 13th:

              Tirthankar Chakraborty headshot

              New Strong Buy Stocks for July 13th

              Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday

                Top Ranked Momentum Stocks to Buy for July 10th

                Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 10th:

                  Top Ranked Momentum Stocks to Buy for July 5th

                  Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 5th:

                    Can The Uptrend Continue for BioLife Solutions (BLFS)?

                    BioLife Solutions, Inc. (BLFS) has been on the move lately as the stock has risen by 44.6% in the past four weeks

                      Surmodics (SRDX) Hits Fresh Highs: Is There Still Room to Run?

                      Surmodics, Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for SRDX for clues.

                        Baxter International (BAX) Hits a 52-Week High, Can the Run Continue?

                        Baxter International Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for BAX for clues.

                          BioLife Solutions (BLFS) Shares March Higher, Can It Continue?

                          As of late, it has definitely been a great time to be an investor in BioLife Solutions, Inc. (BLFS)

                            The Zacks Analyst Blog Highlights: BioLife Solutions, SeaSpine Holdings, Apollo Endosurgery and CareDx

                            The Zacks Analyst Blog Highlights: BioLife Solutions, SeaSpine Holdings, Apollo Endosurgery and CareDx

                              4 Top-Ranked Growth Stocks in MedTech Under $20

                              In the wake of the turbulent political scenario and banking on favorable metrics, these four MedTech stocks stand out as the most suitable picks.

                                Zacks.com featured highlights: H&E Equipment Services, Nomad Foods, Strayer Education, BioLife Solutions and Assembly Biosciences

                                Zacks.com featured highlights: H&E Equipment Services, Nomad Foods, Strayer Education, BioLife Solutions and Assembly Biosciences

                                  New Analyst Coverage Puts the Spotlight on These 5 Stocks

                                  Increased analyst coverage over the last few weeks might translate into solid price appreciation for these stocks.